SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001558370-21-004991
Filing Date
2021-04-28
Accepted
2021-04-28 08:03:15
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A tmb-20210428xdefa14a.htm DEFA14A 24209
2 GRAPHIC tmb-20210428xdefa14a004.jpg GRAPHIC 74258
3 GRAPHIC tmb-20210428xdefa14a003.jpg GRAPHIC 125543
  Complete submission text file 0001558370-21-004991.txt   300614
Mailing Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472
Business Address 490 ARSENAL WAY SUITE 120 WATERTOWN MA 02472 781-996-5252
Kala Pharmaceuticals, Inc. (Filer) CIK: 0001479419 (see all company filings)

IRS No.: 270604595 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-38150 | Film No.: 21861402
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences